Source link : https://newshealth.biz/health-news/survival-in-small-cell-lung-cancer-improved-with-cytotoxic-add-on-to-immunotherapy/
(MedPage Today) — CHICAGO — Patients with extensive-stage small-cell lung cancer (SCLC) lived significantly longer with the addition of cytotoxic agent lurbinectedin (Zepzelca) to maintenance immunotherapy, a large randomized trial showed… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115728 Author : Publish date : 2025-05-22 21:00:00 Copyright for syndicated content belongs to the linked Source.
The post Survival in Small-Cell Lung Cancer Improved With Cytotoxic Add-On to Immunotherapy first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-22 21:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8